A detailed history of Boston Trust Walden Corp transactions in Pfizer Inc stock. As of the latest transaction made, Boston Trust Walden Corp holds 72,582 shares of PFE stock, worth $2.15 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
72,582
Previous 75,579 3.97%
Holding current value
$2.15 Million
Previous $2.1 Million 3.2%
% of portfolio
0.02%
Previous 0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$25.26 - $29.6 $75,704 - $88,711
-2,997 Reduced 3.97%
72,582 $2.03 Million
Q1 2024

Apr 22, 2024

SELL
$25.89 - $29.73 $124,789 - $143,298
-4,820 Reduced 6.0%
75,579 $2.1 Million
Q4 2023

Jan 24, 2024

SELL
$26.13 - $33.94 $98,013 - $127,308
-3,751 Reduced 4.46%
80,399 $2.31 Million
Q3 2023

Oct 18, 2023

SELL
$32.09 - $37.51 $59,270 - $69,280
-1,847 Reduced 2.15%
84,150 $2.79 Million
Q2 2023

Jul 24, 2023

BUY
$36.12 - $41.79 $47,064 - $54,452
1,303 Added 1.54%
85,997 $3.15 Million
Q1 2023

Apr 19, 2023

SELL
$39.39 - $51.28 $169,180 - $220,247
-4,295 Reduced 4.83%
84,694 $3.46 Million
Q3 2022

Oct 19, 2022

BUY
$43.76 - $53.42 $63,233 - $77,191
1,445 Added 1.65%
88,989 $3.89 Million
Q2 2022

Jul 22, 2022

BUY
$46.53 - $55.17 $81,008 - $96,050
1,741 Added 2.03%
87,544 $4.59 Million
Q1 2022

Apr 20, 2022

SELL
$45.75 - $56.69 $172,386 - $213,607
-3,768 Reduced 4.21%
85,803 $4.44 Million
Q4 2021

Jan 21, 2022

BUY
$41.32 - $61.25 $212,508 - $315,008
5,143 Added 6.09%
89,571 $5.29 Million
Q3 2021

Oct 25, 2021

SELL
$39.25 - $50.42 $64,605 - $82,991
-1,646 Reduced 1.91%
84,428 $3.63 Million
Q2 2021

Jul 22, 2021

SELL
$35.91 - $40.68 $9,587 - $10,861
-267 Reduced 0.31%
86,074 $3.37 Million
Q1 2021

Apr 21, 2021

SELL
$33.49 - $37.77 $9,209 - $10,386
-275 Reduced 0.32%
86,341 $3.13 Million
Q4 2020

Jan 15, 2021

BUY
$33.47 - $42.56 $36,147 - $45,964
1,080 Added 1.26%
86,616 $3.19 Million
Q3 2020

Oct 14, 2020

SELL
$31.75 - $37.25 $21,907 - $25,702
-690 Reduced 0.8%
85,536 $3.14 Million
Q2 2020

Jul 23, 2020

SELL
$30.12 - $36.54 $9,789 - $11,875
-325 Reduced 0.38%
86,226 $2.82 Million
Q1 2020

Apr 21, 2020

SELL
$27.03 - $38.62 $145,934 - $208,509
-5,399 Reduced 5.87%
86,551 $2.83 Million
Q4 2019

Jan 10, 2020

BUY
$32.92 - $37.36 $2,962 - $3,362
90 Added 0.1%
91,950 $3.6 Million
Q3 2019

Oct 21, 2019

SELL
$32.49 - $42.13 $52,113 - $67,576
-1,604 Reduced 1.72%
91,860 $3.3 Million
Q2 2019

Jul 25, 2019

BUY
$36.98 - $41.52 $7,543 - $8,470
204 Added 0.22%
93,464 $4.05 Million
Q1 2019

Apr 16, 2019

SELL
$37.5 - $41.2 $107,662 - $118,285
-2,871 Reduced 2.99%
93,260 $3.96 Million
Q4 2018

Jan 17, 2019

SELL
$38.47 - $43.86 $27,313 - $31,140
-710 Reduced 0.73%
96,131 $4.2 Million
Q3 2018

Oct 23, 2018

BUY
$34.47 - $41.81 $1,137 - $1,379
33 Added 0.03%
96,841 $4.27 Million
Q2 2018

Jul 25, 2018

SELL
$32.98 - $35.16 $37,102 - $39,554
-1,125 Reduced 1.15%
96,808 $3.51 Million
Q1 2018

Apr 13, 2018

BUY
$31.91 - $37.02 $132,139 - $153,299
4,141 Added 4.42%
97,933 $3.48 Million
Q4 2017

Jan 29, 2018

BUY
$33.26 - $35.29 $48,526 - $51,488
1,459 Added 1.58%
93,792 $3.4 Million
Q3 2017

Oct 13, 2017

BUY
$31.0 - $34.15 $2.86 Million - $3.15 Million
92,333
92,333 $3.3 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Boston Trust Walden Corp Portfolio

Follow Boston Trust Walden Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.